Joanna Elliott
Family · Woodward, OKNPI 1124419981
Payments from drug & device makers
Across 78 payments — averaging $20.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$440
- AstraZeneca$363
- AbbVie$139
- Amgen$103
- Exact Sciences$75
- Lilly USA, LLC$55
- plus $404 from 15 others
What the payments were for
- Food & beverage$1,578100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $440 |
| AstraZeneca | 17 | $363 |
| AbbVie | 7 | $139 |
| Amgen | 6 | $103 |
| Exact Sciences | 4 | $75 |
| Lilly USA, LLC | 3 | $55 |
| Supernus Pharmaceuticals, Inc. | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
| Johnson & Johnson(2 entities) | 2 | $45 |
| Merck | 2 | $40 |
| Dexcom, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $27 |
| SK Life Science, Inc. | 1 | $27 |
| Viatris Specialty LLC | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Insulet Corporation | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Pfizer | 1 | $14 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$125
How this compares
$1,578 in reported general payments places this provider in the 75th percentile of 2,026 family providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 132 | $130,136 |
| FarxigaDapagliflozin Propanediol | 93 | $72,845 |
| EliquisApixaban | 64 | $43,578 |
| MounjaroTirzepatide | 37 | $41,829 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $32,813 |
| Tresiba Flextouch U-200Insulin Degludec | 40 | $30,668 |
| JardianceEmpagliflozin | 34 | $29,165 |
| XareltoRivaroxaban | 38 | $26,165 |
| RybelsusSemaglutide | 28 | $26,040 |
| TrulicityDulaglutide | 20 | $18,855 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $14,772 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $9,614 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $9,543 |
| Emgality PenGalcanezumab-Gnlm | 11 | $7,465 |
| Repatha SureclickEvolocumab | 13 | $6,951 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $440 | $156,176160 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $363 | $92,059126 claims |
| Lilly USA, LLCMounjaro, Trulicity | $55 | $60,68457 claims |
| PfizerEliquis | $14 | $43,57864 claims |
| Boehringer IngelheimJardiance | $12 | $29,16534 claims |
| Johnson & JohnsonXarelto | $45 | $26,16538 claims |
| MerckJanuvia | $40 | $6,64112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,026 family providers in Oklahoma.
Other family in Woodward
- April WilcoxOklahoma City$245K
- Jeremy MorganOklahoma City$63K
- Samantha BellingerOklahoma City$39K
- Candy WilliamsTulsa$22K
- Lacey HillOklahoma City$20K
- Shelby WrightStillwater$17K
- Brandy ReevesNorman$17K
- Amanda OblanderYukon$17K
- Julia John SamuelOklahoma City$17K
- Jillian OakleafTulsa$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.